Authors' reply

The Lancet

Volumn 379, Issue 9835, 2012, Pages 2426-2427

  Marbán, Eduardo ^a   Malliaras, Konstantinos ^a   Smith, Rachel R ^a   Makkar, Raj ^a   Mendizabal, Adam ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BONE MARROW CELL; CARDIOSPHERE DERIVED CELL; CELL SUBPOPULATION; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; LETTER; MESENCHYMAL STROMA CELL; MUSCLE REGENERATION; PRIORITY JOURNAL; THERAPY EFFECT;

EID: 84862907350     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(12)61064-2     Document Type: Letter

References (5)

1. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008; 94: 730-36. (Pubitemid 351744690)
2. Li TS, Cheng K, Malliaras K, et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012; 59: 942-53.
3. Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010; 106: 971-80.
4. Cheng K, Malliaras K, Smith RR, et al. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in a mouse model of myocardial infarction. Circulation 2011; 124: A17146 (abstr).
5. Malliaras K, Li TS, Luthringer D, et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiospherederived cells. Circulation 2012; 125: 100-12.